NOVA BIO-PHARMA TECHNOLOGIES LIMITED

Active United Kingdom

Manufacture of basic pharmaceutical products

6 employees website.com
Manufacture of basic pharmaceutical products
N

NOVA BIO-PHARMA TECHNOLOGIES LIMITED

Manufacture of basic pharmaceutical products

Founded 17 Jun 2009 Active United Kingdom 6 employees website.com
Manufacture of basic pharmaceutical products
Accounts Submitted 29 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 8 May 2026 Next due 22 May 2027 11 months remaining
Net assets £-810K £636K 2024 year on year
Total assets £802K £282K 2024 year on year
Total Liabilities £2M £355K 2024 year on year
Charges 4
2 outstanding 2 satisfied

Contact & Details

Contact

Full company profile for NOVA BIO-PHARMA TECHNOLOGIES LIMITED (06936355), an active company based in United Kingdom. Incorporated 17 Jun 2009. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type small
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£232.00

Decreased by £29.98k (-99%)

Net Assets

-£809.55k

Decreased by £636.33k (-367%)

Total Liabilities

£1.61M

Increased by £354.54k (+28%)

Turnover

N/A

Employees

6

Increased by 2 (+50%)

Debt Ratio

201%

Increased by 85 (+73%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 2,350,000 Shares £2.35m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Mar 20201,500,000£1.50m£1
5 Oct 2009850,000£850k£1

Officers

Officers

2 active 1 resigned
Status
Karen Alison LeishmanSecretaryUnknownUnknown1 Jan 2024Active
White, James Andrew PittDirectorBritishEngland408 Oct 2020Active

Shareholders

Shareholders (1)

Nova Bio-pharma Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

NOVA BIO-PHARMA TECHNOLOGIES LIMITED Current Company

Charges

Charges

2 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 May 2026MortgageMortgage Satisfy Charge Full
8 May 2026Confirmation StatementConfirmation statement made on 8 May 2026 with no updates
29 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
8 May 2025Confirmation StatementConfirmation statement made on 8 May 2025 with no updates
12 Dec 2024AccountsAnnual accounts made up to 31 Mar 2024
27 May 2026 Mortgage

Mortgage Satisfy Charge Full

8 May 2026 Confirmation Statement

Confirmation statement made on 8 May 2026 with no updates

29 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

8 May 2025 Confirmation Statement

Confirmation statement made on 8 May 2025 with no updates

12 Dec 2024 Accounts

Annual accounts made up to 31 Mar 2024

Recent Activity

Latest Activity

Mortgage Satisfy Charge Full

3 days ago on 27 May 2026

Confirmation statement made on 8 May 2026 with no updates

3 weeks ago on 8 May 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 29 Dec 2025

Confirmation statement made on 8 May 2025 with no updates

1 years ago on 8 May 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 12 Dec 2024